Aminoglycosides Restore Full-length Type VII Collagen by Overcoming Premature Termination Codons: Therapeutic Implications for Dystrophic Epidermolysis Bullosa

類似資料

• De Novo Anti-Type VII Collagen Antibodies in Patients With Recessive Dystrophic Epidermolysis Bullosa
  著者:: Woodley, David T., 等
  出版事項: (2013)
• Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients
  著者:: Woodley, David T., 等
  出版事項: (2017)
• Amlexanox enhances premature termination codon read-through in COL7A1 and expression of full length type VII collagen: potential therapy for recessive dystrophic epidermolysis bullosa
  著者:: Atanasova, Velina S., 等
  出版事項: (2017)
• Characterization of dystrophic epidermolysis bullosa patients for collagen VII therapy
  著者:: Gorell, E.S., 等
  出版事項: (2015)
• The Cartilage Matrix Protein Subdomain of Type VII Collagen Is Pathogenic for Epidermolysis Bullosa Acquisita
  著者:: Chen, Mei, 等
  出版事項: (2007)